Back
Day Range
$17.07
$17.63
52-Week Range
$16.24
$45.30
Volume
1,474,961
50D / 200D Avg
$19.12
/
$29.31
Prev Close
$17.41
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -10.7 | 0.4 |
| P/B | 3.2 | 2.9 |
| ROE % | -29.1 | 3.7 |
| Net Margin % | -28.9 | 3.8 |
| Rev Growth 5Y % | 96.8 | 10.0 |
| D/E | 0.4 | 0.2 |
Key Takeaways
Revenue grew 96.76% annually over 5 years — strong growth
Debt/Equity of 0.41 — conservative balance sheet
Negative free cash flow of -168.04M
Revenue growth is decelerating — 1Y growth trails 5Y average by 32.29%
Capital efficient — spends only 6.55% of revenue on capex
Growth
Revenue Growth (5Y)
96.76%
Revenue (1Y)64.47%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-29.14%
ROIC-7.25%
Net Margin-28.85%
Op. Margin-13.27%
Safety
Debt / Equity
0.41
Current Ratio1.96
Interest Coverage-6.38
Valuation
P/E Ratio
-10.71
P/B Ratio3.18
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 64.47% | Revenue Growth (3Y) | 90.21% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 96.76% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.03B | Net Income (TTM) | -297.58M |
| ROE | -29.14% | ROA | -17.16% |
| Gross Margin | 60.34% | Operating Margin | -13.27% |
| Net Margin | -28.85% | Free Cash Flow (TTM) | -168.04M |
| ROIC | -7.25% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.41 | Current Ratio | 1.96 |
| Interest Coverage | -6.38 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -10.71 | P/B Ratio | 3.18 |
| P/S Ratio | 3.09 | PEG Ratio | -0.20 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 3.19B | Enterprise Value | 2.70B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.03B | 627.24M | 285.14M | 117.01M | 68.83M |
| Net Income | -297.58M | -177.03M | -518.25M | -446.35M | -403.58M |
| EPS (Diluted) | -1.61 | -0.97 | -2.94 | -2.81 | -2.74 |
| Gross Profit | 622.44M | 392.66M | 140.93M | 51.64M | 68.83M |
| Operating Income | -136.86M | -303.24M | -439.49M | -455.62M | -392.29M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.73B | 1.67B | 1.85B | 1.33B | 1.12B |
| Total Liabilities | 723.60M | 629.61M | 597.24M | 586.65M | 353.52M |
| Shareholders' Equity | 1.00B | 1.04B | 1.25B | 744.31M | 765.94M |
| Total Debt | 413.70M | 350.60M | 328.67M | 284.53M | 122.97M |
| Cash & Equivalents | 901.90M | 286.75M | 1.28B | 786.03M | 688.94M |
| Current Assets | 1.25B | 1.28B | 1.50B | 1.10B | 949.85M |
| Current Liabilities | 636.40M | 277.65M | 216.42M | 297.79M | 229.20M |